These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 29431737)

  • 1. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo.
    Li S; Jiang Q; Liu S; Zhang Y; Tian Y; Song C; Wang J; Zou Y; Anderson GJ; Han JY; Chang Y; Liu Y; Zhang C; Chen L; Zhou G; Nie G; Yan H; Ding B; Zhao Y
    Nat Biotechnol; 2018 Mar; 36(3):258-264. PubMed ID: 29431737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nucleolin to obstruct vasculature feeding with an intelligent DNA nanorobot.
    Li H; Liu J; Gu H
    J Cell Mol Med; 2019 Mar; 23(3):2248-2250. PubMed ID: 30592140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Intelligent DNA Nanorobot for Autonomous Anticoagulation.
    Yang L; Zhao Y; Xu X; Xu K; Zhang M; Huang K; Kang H; Lin HC; Yang Y; Han D
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17697-17704. PubMed ID: 32573062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Intelligent DNA Nanorobot with
    Ma W; Zhan Y; Zhang Y; Shao X; Xie X; Mao C; Cui W; Li Q; Shi J; Li J; Fan C; Lin Y
    Nano Lett; 2019 Jul; 19(7):4505-4517. PubMed ID: 31185573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activities of Tumor-killing Nanorobots.
    Li S; Jiang Q; Ding B; Nie G
    Trends Biotechnol; 2019 Jun; 37(6):573-577. PubMed ID: 30826094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots.
    Citartan M; Kaur H; Presela R; Tang TH
    Int J Pharm; 2019 Aug; 567():118483. PubMed ID: 31260780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA origami nanorobot controlled by nucleic acid hybridization.
    Torelli E; Marini M; Palmano S; Piantanida L; Polano C; Scarpellini A; Lazzarino M; Firrao G
    Small; 2014 Jul; 10(14):2918-26. PubMed ID: 24648163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery.
    Wan Y; Wang L; Zhu C; Zheng Q; Wang G; Tong J; Fang Y; Xia Y; Cheng G; He X; Zheng SY
    Cancer Res; 2018 Feb; 78(3):798-808. PubMed ID: 29217761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of tumor endothelial cells and drug delivery.
    Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis.
    Zhao S; Tian R; Wu J; Liu S; Wang Y; Wen M; Shang Y; Liu Q; Li Y; Guo Y; Wang Z; Wang T; Zhao Y; Zhao H; Cao H; Su Y; Sun J; Jiang Q; Ding B
    Nat Commun; 2021 Jan; 12(1):358. PubMed ID: 33441565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
    Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
    PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
    Holmboe S; Hansen PL; Thisgaard H; Block I; Müller C; Langkjær N; Høilund-Carlsen PF; Olsen BB; Mollenhauer J
    PLoS One; 2017; 12(5):e0178286. PubMed ID: 28542563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA Nanorobot Uprises against Cancer.
    Singh HR; Kopperger E; Simmel FC
    Trends Mol Med; 2018 Jul; 24(7):591-593. PubMed ID: 29802035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A logic-gated nanorobot for targeted transport of molecular payloads.
    Douglas SM; Bachelet I; Church GM
    Science; 2012 Feb; 335(6070):831-4. PubMed ID: 22344439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras.
    Lai WY; Wang WY; Chang YC; Chang CJ; Yang PC; Peck K
    Biomaterials; 2014 Mar; 35(9):2905-14. PubMed ID: 24397988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Nanobots - Emerging Customized Nanomedicine in Oncology.
    Singh R; Deshmukh R
    Curr Drug Deliv; 2023; 20(2):111-126. PubMed ID: 35362383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy.
    Tang L; Tong R; Coyle VJ; Yin Q; Pondenis H; Borst LB; Cheng J; Fan TM
    ACS Nano; 2015 May; 9(5):5072-81. PubMed ID: 25938427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.